HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.
Emerging Treatments and Technologies
The impact of new therapies and technologies on health care includes numerous improvements to health outcomes, as well as an increase in cost and problems about access equality. New medicines, monitoring, and new healthcare enabling technology represent a once-in-a-generation potential to transform the lives of diabetics. These advancements allow for more accurate monitoring of blood glucose levels, as well as more precise insulin dose and administration. New insulins and delivery technologies are being developed to combat both hyperglycemia and hypoglycemia while also extending the time in range. There are already information systems that can be used to combine data from previously distinct systems into new models of connected care.
- Insulin analogs
- Inhaled insulin
- Smart insulin
- Insulin delivery vehicle
Committee Members
Mahir Khalil Ibrahim Jallo
Gulf Medical University, Canada
Yong Xiao Wang
Albany Medical College, United States
F Buck Willis
Christian College of Medicine, Belize Diabetes 2025 Speakers
Sujith Rajan
NYU Long Island School of Medicine, United States
Amy Gutman
AdventHealth; Tough Love MD, United States
Anil Harrison
Midwestern University, United States
Jun Dai
Des Moines University, United StatesSubmit your abstract Today
Title : Adipose MTP deficiency protects against hepatic steatosis by upregulating PPAR activity
Sujith Rajan, NYU Long Island School of Medicine, United States
Title : Diabetes reduction (pre-diabetes and type 2) with integrative medicine
F Buck Willis, Christian College of Medicine, Belize
Title : Important roles and mechanisms of novel calcium signaling in diabetes-induced vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : Does winter melon (Benincasa hispida) improves nutritional values and ameliorating glycaemic parameters ?
Wan Rosli Wan Ishak, Universiti Sains Malaysia, Malaysia
Title : The menopausal mind: Reframing female senescence as a neuroendocrine disorder with root cause management strategies
Amy Gutman, AdventHealth; Tough Love MD, United States
Title : AI receptor binding studies reveal GPR146 conformational states across diabetic phenotypes: Analysis of C-peptide and insulin interactions in cholesterol metabolism, cortisol regulation, and the vitamin D-renin-angiotensin axis
David Petch, utR Biotech, Canada